Watch-and-wait policyversusrituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma-Reference-Cited by-同舟云学术

Watch-and-wait policyversusrituximab-combined chemotherapy in Japanese patients with intestinal follicular lymphoma

Published:2018-03-25 Issue:8 Volume:33 Page:1461-1468
ISSN:0815-9319
Container-title:Journal of Gastroenterology and Hepatology
language:en
Short-container-title:Journal of Gastroenterology and Hepatology

Author:

Tari Akira¹,Kitadai Yasuhiko²,Mouri Ritsuo¹,Takigawa Hidehiko³,Asaoku Hideki⁴,Mihara Keiichiro⁵,Takata Katsuyoshi⁶,Fujihara Megumu⁷,Yoshino Tadashi⁶,Koga Tadashi⁸,Fujimori Shunji⁹,Tanaka Shinji¹⁰,Chayama Kazuaki³

Affiliation:

1. Division of Gastroenterology, Department of Internal Medicine; Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital; Hiroshima Japan

2. Department of Health and Science; Prefectural University of Hiroshima; Hiroshima Japan

3. Department of Gastroenterology and Metabolism; Hiroshima University; Hiroshima Japan

4. Department of Hematology; Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital; Hiroshima Japan

5. Department of Hematology and Oncology, Research Institute for Radiation Biology and Medicine; Hiroshima University; Hiroshima Japan

6. Department of Pathology; Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences; Okayama Japan

7. Department of Pathology; Hiroshima Red Cross Hospital & Atomic-bomb Survivors Hospital; Hiroshima Japan

8. Shin Nippon Biomedical Laboratories, Ltd.; Kagoshima Japan

9. Department of Gastroenterology; Chiba Hokusou Hospital, Nippon Medical School; Chiba Japan

10. Department of Endoscopy and Medicine, Graduate School of Biomedical and Health Science; Hiroshima University; Hiroshima Japan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jgh.14100/fullpdf

Reference31 articles.

1. Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced- stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group;Hiddemann;Blood,2005

2. New treatment options have changed the survival of patients with follicular lymphoma;Fisher;J. Clin. Oncol.,2005

3. Immunochemotherapy with rituximab and overall survival in patients with indolent or mantle cell lymphoma: a systematic review and meta-analysis;Schulz;J. Natl. Cancer Inst.,2007

4. Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma;Marcus;J. Clin. Oncol.,2008

5. Improved survival in patients with early stage low-grade follicular lymphoma treated with radiation: a Surveillance, Epidemiology, and End Results database analysis;Pugh;Cancer,2010

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene targeted and immune therapies for nodal and gastrointestinal follicular lymphomas;World Journal of Gastroenterology;2023-12-28

2. Disease surveillance evaluation of primary small-bowel follicular lymphoma using capsule endoscopy images based on a deep convolutional neural network (with video);Gastrointestinal Endoscopy;2023-12

3. Recent advances in treatment of nodal and gastrointestinal follicular lymphoma;World Journal of Gastroenterology;2023-06-21

4. Long-term outcomes of patients with primary intestinal follicular lymphoma managed with watch-and-wait strategy;Scientific Reports;2023-04-11

5. Duodenal-type follicular lymphoma more than 10 years after treatment intervention: A retrospective single-center analysis;World Journal of Gastrointestinal Oncology;2022-08-15